Journals / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 1

Neutrophil serine proteases and their endogenous inhibitors in coronary artery ectasia patients

Pages
23–28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The levels of TNF-?, IL-8, and endotoxin were unchanged in the CAE group compared with those in the CAD group.Conclusion: Neutrophils may participate in the process of vessel extracellular matrix destruction and coronary ectasia by releasing NSPs in a non-classical manner

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Proteolytic enzymes possibly contribute to coronary artery ectasia (CAE).
📊
Key Findings & Data:This study aimed to determine whether neutrophils, neutrophil serine proteases (NSPs), and their endogenous inhibitors participated in the pathological process of CAE.Methods: The study consisted of 30 patients with CAE, 30 patients with coronary artery disease (CAD), and 29 subjects with normal coronary arteries (Control).
💡
Conclusion & Impact:The levels of TNF-?, IL-8, and endotoxin were unchanged in the CAE group compared with those in the CAD group.Conclusion: Neutrophils may participate in the process of vessel extracellular matrix destruction and coronary ectasia by releasing NSPs in a non-classical manner
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Proteolytic enzymes possibly contribute to coronary artery ectasia (CAE). This study aimed to determine whether neutrophils, neutrophil serine proteases (NSPs), and their endogenous inhibitors participated in the pathological process of CAE.Methods: The study consisted of 30 patients with CAE, 30 patients with coronary artery disease (CAD), and 29 subjects with normal coronary arteries (Control). The following circulating items were measured: the main NSPs, including human neutrophil elastase (HNE), cathepsin G (CG), and proteinase 3 (PR3); soluble elastin (sElastin), which was a degradation product of elastin fibres; NSP inhibitors such as ?1-protease inhibitor (?1-PI), ?2-macroglobulin (?2-MG), secretory leucoprotease inhibitor (SLPI), and elafin; as well as two neutrophil activation markers (myeloperoxidase and lactoferrin) and three classic neutrophil activators [tumor necrosis factor-? (TNF-?), interleukin-8 (IL-8), and bacterial endotoxin].Results: The levels of HNE, CG, and sElastin were elevated in the CAE group. The levels of ?1-PI and ?2-MG were also significantly increased in the CAE group. The levels of myeloperoxidase and lactoferrin were higher in the CAE group. The levels of TNF-?, IL-8, and endotoxin were unchanged in the CAE group compared with those in the CAD group.Conclusion: Neutrophils may participate in the process of vessel extracellular matrix destruction and coronary ectasia by releasing NSPs in a non-classical manner

🔖

Cite This Article

LIU, R., CHEN, L., WU, W., CHEN, H., ZHANG, S. (2016). Neutrophil serine proteases and their endogenous inhibitors in coronary artery ectasia patients. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 1, 23–28. https://ajindex.com/articles/365440

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Antoniadis AP, Chatzizisis YS, Giannoglou GD. Pathogenetic mecha- nisms of coronary ectasia. Int J Cardiol 2008; 130: 335-43.
  2. Özcan OU, Güleç S. Coronary artery ectasia. Cor et Vasa 2013; 55: e242-7. Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV, Gorlin R. Clinical significance of coronary arterial ectasia. Am J Cardiol 1976; 37: 217-22.
  3. Virmani R, Robinowitz M, Atkinson JB, Forman MB, Silver MD, McAllister HA. Acquired coronary arterial aneurysms: an autopsy study of 52 patients. Hum Pathol 1986; 17: 575-83.
  4. Gu Y, Lee HM, Simon SR, Golub LM. Chemically modified tetracy- cline-3 (CMT-3): a novel inhibitor of the serine proteinase, elastase. Pharmacol Res 2011; 64: 595-601. Pham CT. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 2006; 6: 541-50.
  5. Groutas WC, Dou D, Alliston KR. Neutrophil elastase inhibitors. Expert Opin Ther Pat 2011; 21: 339-54.
  6. Kawabata K, Hagio T, Matsuoka S. The role of neutrophil elastase in acute lung injury. Eur J Pharmacol 2002; 451: 1-10.
  7. Lee WL, Downey GP. Leukocyte elastase: physiological functions and role in acute lung injury. Am J Respir Crit Care Med 2001; 164: 896-904.
  8. Siedle B, Hrenn A, Merfort I. Natural compounds as inhibitors of human neutrophil elastase. Planta Med 2007; 73: 401-20.
  9. Korkmaz B, Horwitz MS, Jenne DE, Gauthier F. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 2010; 62: 726-59.
  10. Erayman A, Şen N. Neutrophil-lymphocyte ratio and C-reactive protein may be correlated in patients with coronary artery ectasia. Angiology 2014; 65: 84-5.
  11. Balta S, Demirkol S, Çelik T, Küçük U, Ünlü M, Arslan Z, et al. Association between coronary artery ectasia and neutrophil-lym- phocyte ratio. Angiology 2013; 64: 627-32.
  12. Yalçın AA, Topuz M, Aktürk IF, Çelik O, Ertürk M, Uzun F, et al. Is there a correlation between coronary artery ectasia and neutro- phil-lymphocyte ratio? Clin Appl Thromb Hemost 2014 Jan 24. Epub ahead of print. Gullberg U, Andersson E, Garwicz D, Lindmark A, Olsson I. Biosynthesis, processing and sorting of neutrophil proteins: insight into neutrophil granule development. Eur J Haematol 1997; 58: 137-53.
  13. Korkmaz B, Moreau T, Gauthier F. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physio- pathological functions. Biochimie 2008; 90: 227-42.
  14. Nussbaum C, Klinke A, Adam M, Baldus S, Sperandio M. Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovasc